Kawashima Motoko, Yamada Masakazu, Suwaki Kazuhisa, Shigeyasu Chika, Uchino Miki, Hiratsuka Yoshimune, Yokoi Norihiko, Tsubota Kazuo
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Department of Ophthalmology, Kyorin University, Tokyo, Japan.
Adv Ther. 2017 Mar;34(3):732-743. doi: 10.1007/s12325-017-0487-x. Epub 2017 Feb 8.
The aim of this study was to investigate the clinical characteristics and practice pattern of patients with dry eye disease (DED) in eye clinics across Japan.
A multi-center, cross-sectional study was conducted among patients with DED who visited eye clinics in Japan. Subjective symptoms, patient's background, ocular surface features, and tear function were evaluated. Main outcome measures were tear break-up time (TBUT), Schirmer I value, kerato-conjunctival staining score, and dry eye symptom questionnaire score.
Initially, 463 subjects were enrolled, and 449 cases (63 male and 386 female; mean age, 62.6 ± 15.7 years) were included in the final analysis. Overall, 94.9% of patients had a shortened TBUT (≤5 s), and 54.6% had an aqueous tear deficiency (Schirmer I value ≤5 mm). The most prevalent subtype of dry eye was aqueous-deficient dry eye, which was present in 35.0% of all patients, followed by short-BUT-type dry eye, which was seen in 26.7%.
The two most common DED subtypes were aqueous-deficient and short-BUT-type dry eye. Shortened TBUT is the most common feature of dry eye, regardless of subtype. The current treatment choice mainly consisted of hyaluronic acid, two novel mucin secretagogues, diquafosol and rebamipide, and steroidal eye drops.
University Hospital Medical Information Network: UMIN (registries no. UMIN 000015890).
Japan Dry Eye Society, Tokyo, Japan, and Santen Pharmaceutical Co., Ltd., Osaka, Japan.
本研究旨在调查日本眼科诊所中干眼症(DED)患者的临床特征及诊疗模式。
对日本眼科诊所的干眼症患者进行了一项多中心横断面研究。评估了主观症状、患者背景、眼表特征及泪液功能。主要观察指标为泪膜破裂时间(TBUT)、Schirmer I试验值、角膜结膜染色评分及干眼症状问卷评分。
最初纳入463名受试者,最终分析纳入449例(男性63例,女性386例;平均年龄62.6±15.7岁)。总体而言,94.9%的患者TBUT缩短(≤5秒),54.6%的患者存在水样泪液缺乏(Schirmer I试验值≤5毫米)。最常见的干眼亚型是水样液缺乏型干眼,占所有患者的35.0%,其次是短TBUT型干眼,占26.7%。
两种最常见的DED亚型是水样液缺乏型和短TBUT型干眼。无论亚型如何,TBUT缩短是干眼最常见的特征。目前的治疗选择主要包括透明质酸、两种新型粘蛋白分泌促进剂(地夸磷索和瑞巴派特)以及类固醇眼药水。
大学医院医学信息网络:UMIN(注册号UMIN 000015890)。
日本干眼症协会,日本东京;参天制药株式会社,日本大阪。